NEURODEGNET

 

OBJECTIVES


  1. 1. To promote clinical, genetic, basic and traslational research of human neurodegenerative diseases, in particular ataxias, dementias, Parkinson and other movement disorders.

  2. 2. To promote training of Clinical, Geneticists and Basic Scientists to investigate the different aspects of human neurodegeneration.

  3. 3. To translate the basic research into biomarker discovery and obtaining effective therapeutic drugs.

  4. 4. To promote clinical trials in human patients.

 

RESEARCH GROUPS


  1. Group 1. Katrin Beyer, University Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB).

  2. Group 2. Matilde Calopa Garriga, Carlos Casasnovas Pons, University Hospital of Bellvitge, IDIBELL.

  3. Group 3. David Genís i Batlle, University Hospital of Girona Dr. Josep Trueta.

  4. Group 4. Lydia Giménez Llort, Universitat Autònoma de Barcelona (UAB).

  5. Group 5. F.Xavier Gomis-Rüth, Maria Solà i Vilarubias,  Molecular Biology Institute of Barcelona, CSIC.

  6. Group 6. Pilar Latorre, Ramiro Alvarez, Manuel Lozano, University Hospital Germans Trias i Pujol, UAB.

  7. Group 7. Antoni Matilla Dueñas, Ivelisse Sánchez Díaz, IGTP, UAB.

  8. Group 8. Sandra Villegas, Universitat Autònoma de Barcelona (UAB).

  9. Group 9. Victor Volpini Bertran, Centre for Genetic-Molecular Diagnosis of inherited diseases, IDIBELL.

 

Welcome          Publications          News          Blog             Jobs

A multidisciplinary Scientific Consortium dedicated to the investigation of human neurodegenerative diseases with the ultimate goal of designing effective therapeutic strategies.

NEURODEGNET Coordinator


Antoni Matilla Dueñas

Department of Neuroscience and Neurology Service

Health Sciences Research Institute Germans Trias i Pujol (IGTP)

Universitat Autònoma de Barcelona (UAB)

Tel.: +34 934 978 687
Fax: +34 934 978 654

amatilla@neurodeg.net